Recent News

Web icon Corona Update

1-June-2020   H.E.L Group continues to respond to the fast-changing situation that the Covid-19 pandemic presents. Our primary concern throughout the…

Find out more
Mert Sahin joins H.E.L Group as General Manager and Senior Vice President of North American Operations GE Healthcare Commercial Executive brings a breadth of experience in scientific instrumentation and global markets to drive North American presence Borehamwood, UK, 01 June 2020: H.E.L Group (H.E.L), a global developer and manufacturer of innovative laboratory tools for process optimization, safety and scale-up, today announced the appointment of Mert Sahin Ph.D. as General Manager and Senior Vice President of H.E.L Inc., the Company’s North American subsidiary. He will lead a strong presence in North America, with a focus on customer-centered service and support. Mert has a background in commercial leadership across the Life Sciences industry. He joins H.E.L from GE Healthcare where he held senior executive roles, most recently as Chief Marketing Officer for GE’s Medical Imaging business. During his time at GE, he held various roles across EMEA & North America within Healthcare, in particular Pharmaceuticals. Bioprocess and Medical Devices. Prior to GE, he held roles in the Life Sciences and Diagnostics industries. Originally from Turkey, Mert completed his Ph.D. at the University of Hamburg, Germany and lived in multiple countries before relocating to Boston, MA in 2016. Mert’s appointment follows other recent leadership team announcements at H.E.L across operational and commercial functions, in line with the Company’s strong growth and service support initiatives.

GE Healthcare Commercial Executive brings a breadth of experience in scientific instrumentation and global markets to drive North American presence Borehamwood,…

Find out more
H.E.L Group appoints Kevin O’Donovan as Chair Appointment brings significant Board and commercial experience to deliver sustainable company growth Borehamwood, UK, 07 April 2020: H.E.L Group (H.E.L), a global developer and manufacturer of innovative laboratory tools for process optimization, safety and scale-up, today announced the appointment of Kevin O’Donovan as Chair of the H.E.L Board of Directors. Kevin takes over from interim Chair, Jon Andrew, and will guide the Company to deliver sustainable growth while continuing to help customers solve complex scientific challenges. Kevin is a Business Angel and has built up a portfolio of investments in the life sciences over the last 20 years, sitting on a number of Boards as Chair or Non-Executive Director. Several of these companies have been successfully sold, with listings on Ofex and AIM. Previously, Kevin founded the molecular biology instrumentation company, Hybaid, and directed its growth from concept to trade sale for £12 million. Here his expertise lay in export, and he successfully implemented a global network of 40 companies. Kevin has an MBA which he obtained from the UK’s Kingston Business School. The announcement of the new Chair follows a number of recent leadership team appointments and builds on the Company’s strong growth initiatives and focus on strengthening production and service support.

Appointment brings significant Board and commercial experience to deliver sustainable company growth Borehamwood, UK, 07 April 2020: H.E.L Group (H.E.L), a…

Find out more